Eagle Pharmaceuticals

BELRAPZO

View Prices
  1. Home
    2.  / 
  2. J Code
    3.  / BELRAPZO – J9036

Manufacturer:

Eagle Pharmaceuticals

Name:

BELRAPZO

HCPCS Code Descriptor:

Injection, bendamustine hydrochloride, (belrapzo/bendamustine), 1 mg

Category:

J Code

HCPCS:

J9036

NDC(s):

42367-0521-25, 42367-0520-25, 60505-6228-00

Primary Type:

Oncology

Generic Status:

Single-Source

Route of Administration:

Intravenous

About:

BELRAPZO is an Oncology drug manufactured by Eagle Pharmaceuticals and administered via the Intravenous route of administration. The J Code: J9036 is aligned to the drug BELRAPZO.

Belrapzo is used to treat certain types of cancer and belongs to group of drugs known as alkylating agents. Belrapzo is manufactured by both Eagle Pharmaceuticals and Baxter Healthcare. There are two J Codes for Belrapzo: J9036 and J9306. Patient assistance programs for this medication can be found through Eagle Pharmaceuticals at the Eagle Can: Care & Access Network.

View Prices

Access Pricing and More By Registering

Register Now

HCPCS Added Date:

7/1/19

HCPCS Effective Date:

7/1/19

HCPCS Short Description:

Inj. belrapzo/bendamustine

Billing and Coding Guide:

Not Found

Patient Assistance:

https://belrapzo.com/reimbursement/

BELRAPZO - J9036